0.49% 0.05

Neuropace Inc (NPCE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Neuropace Inc-Aktie (NPCE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.62% 18.12	18.01	16.43	16.51	14.47
Cost Of Revenue	7.03% 4.781	4.467	4.194	4.538	4.10
Gross Profit	1.49% 13.34	13.54	12.23	11.97	10.37
Operating Expenses	12.33% 20.89	18.60	18.18	19.83	18.69
Interest Income/Expense	0.98% 2.258	2.236	2.191	2.125	1.965
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	11.30% 25.67	23.06	22.38	24.36	22.79
Operating Income/Loss	49.38% -7.545	-5.051	-5.95	-7.854	-8.319
Income/Loss From Continuing Operations Before Tax	0.62% 18.12	18.01	16.43	-9.124	-10.38
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	43.95% -8.925	-6.20	-7.257	-9.124	-10.38
Net Income/Loss	43.95% -8.925	-6.20	-7.257	-9.124	-10.38
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8,756% 28.29	0.3194	26.02	25.47	25.10
Diluted Average Shares	8,756% 28.29	0.3194	26.02	25.47	25.10
Basic Earnings Per Share	45.45% -0.32	-0.22	-0.28	-0.36	-0.41
Diluted Earnings Per Share	45.45% -0.32	-0.22	-0.28	-0.36	-0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$217.47

0.65%

ZBH

$112.02

1.25%

PHG

$27.15

0.89%

DXCM

$78.10

0.21%

GEHC

$83.00

0.59%

$72.07

0.73%